Related Experiment Video
Updated: Mar 6, 2026

Hypothalamic Kisspeptin Neurons as a Target for Whole-Cell Patch-Clamp Recordings
Published on: March 17, 2023
Kisspeptin-10 treatment generated specific GnRH expression in cells differentiated from rhesus monkey derived Lyon
Tanzeel Huma1, Xintian Hu2, Yuanye Ma3
1Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, PR China; Laboratory of Reproductive Neuroendocrinology, Department of Animal Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan; Institute of Molecular Biology and Biotechnology, University of Lahore, Lahore, Pakistan; Department of Genetics, Xuzhou Medical College, Xuzhou city, PR China; Institute of Audiology and Speech Science of Xuzhou Medical College, Xuzhou city, PR China.
Abstract:
Embryonic stem cells (ESCs) have enormous potential as novel cell-based therapies, but their effectiveness depends on stem cell differentiation and specific signaling regulators, which remain poorly understood. In this study, a kisspeptin peptide (KP-10) was used at different dosages to determine whether rhesus macaque-derived tau GFP-Lyon ES cells underwent kisspeptin-specific neuronal differentiation. It was found that KP-10 exhibited an anti-proliferative effect on the cells and led to morphological changes and cellular differentiation consistent with neuronal stem cell (NSC) development. The cells differentiated into Gonadotrophin Releasing Hormone (GnRH) neuronal-like cell types in response to the KP-10 treatment. There has been a previously observed connection between kisspeptin signaling, GnRH neurons and their dysfunction found in congenital disorders like idiopathic hypogonadotropic hypogonadism (IHH). Although therapeutics are a still a far-off goal, the formation and development of GnRH-positive neuronal-like cells following the application of KP-10 to Lyon NSC cells opens the door for future NSC-based therapies to treat specific reproductive disorders.
Insights
Kisspeptin peptide (KP-10) induced neuronal stem cell (NSC) differentiation into Gonadotrophin Releasing Hormone (GnRH) neuronal-like cells. This finding offers potential for new therapies targeting reproductive disorders.
Area of Science:
- Stem cell biology
- Neuroendocrinology
- Reproductive medicine
Background:
- Embryonic stem cells (ESCs) hold promise for cell-based therapies.
- Stem cell differentiation and regulation are critical but not fully understood.
- Kisspeptin signaling is linked to Gonadotrophin Releasing Hormone (GnRH) neurons and reproductive disorders like idiopathic hypogonadotropic hypogonadism (IHH).
Purpose of the Study:
- To investigate the effect of kisspeptin peptide (KP-10) on neuronal differentiation of rhesus macaque-derived ESCs.
- To determine if KP-10 can induce specific neuronal cell types.
Main Methods:
- Treatment of tau GFP-Lyon ESCs with varying dosages of KP-10.
- Observation of cellular morphology, proliferation, and differentiation markers.
- Identification of differentiated cell types using specific markers.
Main Results:
- KP-10 demonstrated an anti-proliferative effect on the ESCs.
- Morphological changes and differentiation consistent with neuronal stem cell (NSC) development were observed.
- ESCs differentiated into Gonadotrophin Releasing Hormone (GnRH) neuronal-like cells.
Conclusions:
- KP-10 promotes the differentiation of ESCs into GnRH-neuronal-like cells.
- This research provides a foundation for developing novel NSC-based therapies for reproductive disorders.
- Further research is needed to translate these findings into clinical therapeutics.

